Unknown

Dataset Information

0

A cell-based fascin bioassay identifies compounds with potential anti-metastasis or cognition-enhancing functions.


ABSTRACT: The actin-bundling protein fascin is a key mediator of tumor invasion and metastasis and its activity drives filopodia formation, cell-shape changes and cell migration. Small-molecule inhibitors of fascin block tumor metastasis in animal models. Conversely, fascin deficiency might underlie the pathogenesis of some developmental brain disorders. To identify fascin-pathway modulators we devised a cell-based assay for fascin function and used it in a bidirectional drug screen. The screen utilized cultured fascin-deficient mutant Drosophila neurons, whose neurite arbors manifest the 'filagree' phenotype. Taking a repurposing approach, we screened a library of 1040 known compounds, many of them FDA-approved drugs, for filagree modifiers. Based on scaffold distribution, molecular-fingerprint similarities, and chemical-space distribution, this library has high structural diversity, supporting its utility as a screening tool. We identified 34 fascin-pathway blockers (with potential anti-metastasis activity) and 48 fascin-pathway enhancers (with potential cognitive-enhancer activity). The structural diversity of the active compounds suggests multiple molecular targets. Comparisons of active and inactive compounds provided preliminary structure-activity relationship information. The screen also revealed diverse neurotoxic effects of other drugs, notably the 'beads-on-a-string' defect, which is induced solely by statins. Statin-induced neurotoxicity is enhanced by fascin deficiency. In summary, we provide evidence that primary neuron culture using a genetic model organism can be valuable for early-stage drug discovery and developmental neurotoxicity testing. Furthermore, we propose that, given an appropriate assay for target-pathway function, bidirectional screening for brain-development disorders and invasive cancers represents an efficient, multipurpose strategy for drug discovery.

SUBMITTER: Kraft R 

PROVIDER: S-EPMC3529353 | biostudies-literature | 2013 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

A cell-based fascin bioassay identifies compounds with potential anti-metastasis or cognition-enhancing functions.

Kraft Robert R   Kahn Allon A   Medina-Franco José L JL   Orlowski Mikayla L ML   Baynes Cayla C   López-Vallejo Fabian F   Barnard Kobus K   Maggiora Gerald M GM   Restifo Linda L LL  

Disease models & mechanisms 20120823 1


The actin-bundling protein fascin is a key mediator of tumor invasion and metastasis and its activity drives filopodia formation, cell-shape changes and cell migration. Small-molecule inhibitors of fascin block tumor metastasis in animal models. Conversely, fascin deficiency might underlie the pathogenesis of some developmental brain disorders. To identify fascin-pathway modulators we devised a cell-based assay for fascin function and used it in a bidirectional drug screen. The screen utilized c  ...[more]

Similar Datasets

| S-EPMC7466159 | biostudies-literature
| S-EPMC2857318 | biostudies-literature
| S-SCDT-EMM-2021-14552P | biostudies-other
| S-EPMC6589821 | biostudies-literature
| S-EPMC10379093 | biostudies-literature
| S-EPMC8308569 | biostudies-literature
| S-EPMC5423182 | biostudies-other
2012-05-01 | GSE35105 | GEO
| S-EPMC6486884 | biostudies-literature
| S-EPMC5746366 | biostudies-literature